Dr. Brett Joseph Carroll, MD

Dr. Carroll practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Carroll's NPI, 1669768123, was assigned on June 23, 2011. Dr. Carroll graduated from University of Massachusetts Medical School in 2011. Dr. Carroll holds Massachusetts license 257512.

Dr. Carroll's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Carroll's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Carroll is also affiliated with Winchester Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Carroll to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carroll practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Carroll's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Carroll is licensed in Massachusetts.

CMS data shows 1,255 Medicare services from Dr. Carroll across 19 procedure codes in 2024, for 911 Medicare patients. Medicare paid $65,424 for them.

CMS counts 911 Medicare patients who saw Dr. Carroll in 2024. The largest group is 65 to 74, with 368 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carroll's median patient age at 70, with 46% women.

In 2024, Dr. Carroll wrote 2,119 Medicare Part D claims for 325 patients. 77% of them were for generic drugs. CMS names the drug for 1,955 of them, across 25 drugs with 11 or more claims each, at $550,496 in total drug cost. In 2023, CMS named 1,691 claims across 25 drugs.

Dr. Carroll accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carroll as offering telehealth.

Dmand AI links 65 papers to Dr. Carroll, published from 2012 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Pulmonary Embolism, Anticoagulants and Thrombolytic Therapy. Dr. Carroll has published most often in Vasc Med. Dr. Carroll's most frequent co-authors are Eric Alexander Secemsky, MD, MS, Sebastian Ekkehard Beyer, MD, MPH and Warren J. Manning, MD.

Dmand AI links Dr. Carroll to 1 clinical trial. Conditions studied include Pulmonary Embolism and Embolism.

CMS Open Payments shows 2 general payments to Dr. Carroll from 2 drug and device companies from 2016 to 2017. Honoraria make up the largest share, 92% of the total. Pfizer Inc. paid the most, $1,500.

Dr. Carroll graduated from University of Massachusetts Medical School in 2011.